Translocation of shiga toxin across polarized intestinal cells in tissue culture

Infection and Immunity

Volumn 64, Issue 8, 1996, Pages 3294-3300

  Acheson, D W K ^a   Moore, R ^b   De Breucker, S ^a   Lincicome, L ^a   Jacewicz, M ^a   Skutelsky, E ^c   Keusch, G T ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; HORSERADISH PEROXIDASE; INULIN; POLYCARBONATE; SHIGA TOXIN;

ANIMAL CELL; ARTICLE; CELL POLARITY; CELL TRANSPORT; CHO CELL; CONTROLLED STUDY; ESCHERICHIA COLI; HELA CELL; HUMAN; HUMAN CELL; INTESTINE CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0030036238     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.8.3294-3300.1996     Document Type: Article

References (39)

1. Acheson, D. W. K., S. De Breucker, A. Donohue-Rolfe, K. Kozak, A. Yi, and G. T. Keusch. 1994. Enzyme immunoassay for direct detection of Shiga-like toxins in stool samples, abstr. B-62, p. 39. In Abstracts of the 94th General Meeting of the American Society for Microbiology 1994. American Society for Microbiology, Washington, D.C.
2. Acheson D. W. K., A. Donohue-Rolfe, and G. T. Keusch. 1991. The family of Shiga and Shiga-like toxins, p. 415-433. In J. E. Alouf and J. H. Freer (ed.), Sourcebook of bacterial protein toxins. Academic Press Ltd., London.
3. Boffa, L. C., R. J. Gruss, and V. G. Allfrey. 1982. Manifold effects of sodium butyrate on nuclear function. Selective and reversible inhibition of phosphorylation of histories H1 and H2A and impaired methylation of lysine and arginine residues in nuclear protein fractions. J. Biol. Chem. 256:9612-9621.
4. Brown, M. S., R. G. W. Anderson, and J. L. Goldstein. 1983. Recycling receptors: the round trip itinerary of migrant membrane proteins. Cell 32: 663-667.
5. Calderwood, S. B., D. W. K. Acheson, G. T. Keusch, et al. 1996. Proposed new nomenclature for SLT (VT) family. ASM News 62:118-119.
6. Dharmsathaphorn, K., J. A. McRoberts, K. G. Mandel, L. D. Tisdale, and H. Masui. 1984. A human colonic tumor cell line that maintains vectorial electrolyte transport. Am. J. Physiol. 246:G204-G208.
7. Donnenberg, M. S., and J. B. Kaper. 1992. Enteropathogenic Escherichia coli. Infect. Immun. 60:3953-3961.
8. Donohue-Rolfe, A., D. W. K. Acheson, A. V. Kane, and G. T. Keusch. 1989. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glyeoprotein and production of cross-reactive monoclonal antibodies. Infect. Immun. 57:3888-3893.
9. Hecht, G., A. Koutsouris, C. Pothoulakis, J. T. LaMont, and J. L. Madara. 1992. Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. Gastroenterology 102:416-423.
10. Heyman, M., A.-M. Crain-Denoyelle, S. M. Nath, and J-F Desjeuz. 1990. Quantification of protein transcytosis in the human colon carcinoma cell line CaC0-2. J. Cell. Physiol. 143:391-395.
11. Ismaili, A., D. J. Philpott, M. T. Dytoc, and P. M. Sherman. 1995. Signal transduction responses following adhesion of Verocytotoxin-producing Escherichia coli. Infect. Immun. 63:3316-3326.
12. Jacewicz, M. S., D. W. K. Acheson, M. Mobassaleh, A. Donohue-Rolfe, K. A. Balasubramanian, and G. T. Keusch. 1995. Maturational regulation of globotriaosylceramide, the Shiga-like toxin I receptor, in cultured human gut epithelial cells. J. Clin. Invest. 96:1328-1335.
13. Karmali, M. A. 1989. Infection by Verocytotoxin-producing Escherichia coli. Clin Microbiol. Rev. 2:15-38.
14. Karmali, M. A., M. Petric, C. Lim, P. C. Fleming, G. S. Arbus, and H. Lior. 1985. The association between idiopathic hemolytic uremic syndrome and infection by Verocytotoxin-producing Escherichia coli. J. Infect. Dis. 151: 775-782.
15. Kelly, J., A. Oryshak, M. Wenetsek, J. Grabiec, and S. Handy. 1990. The colonic pathology of Escherichia coli O157:H7 infection. Am. J. Surg. Pathol. 14:87-92.
16. Keusch, G. T., and M. Jacewicz. 1990. Primary amines and chloroquine inhibit cytotoxic responses to Shigella toxin and permit antibody rescue of toxin treated cells. Biochem. Biophys. Res. Commun. 121:69-76.
17. Keusch, G. T., M. Jacewicz, D. W. K. Acheson, A. Donohue-Rolfe, A. V. Kane, and R. H. McCluer. 1995. Globotriaosylceramide, Gb3. is an alternative functional receptor for Shiga-like toxin 2e. Infect. Immun. 63:1138-1141.
18. Lencer, W. I., S. Moe, P. A. Rufo, and J. L. Madara. 1995. Transcytosis of cholera toxin subunits across model human intestinal epithelia. Proc. Natl. Acad. Sci. 92:10094-10098.
19. Levine, M. M. 1987. Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive. enterohemorrhagic and enteroadherent. J. Infect. Dis. 155:377-389.
20. Louise, C. B., and T. G. Obrig. 1992. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect. Immun. 60:1536-1543.
21. MacLeod, D. L., C. L. Gyles, and B. P. Wilcock. 1991. Reproduction of edema disease of swine with purified Shiga-like toxin II variant. Vet. Pathol. 28:66-73.
22. Madara, J. L., R. Moore, and S. Carlson. 1987. Alteration of intestinal tight junction structure and permeability by cytoskeletal contraction. Am J. Physiol. 253:C854-C861.
23. Moake, J. L. 1994. Haemolytic-uraemic syndrome: basic science. Lancet 343:393-397.
24. Neill, M. A. 1994. Pathogenesis of Escherichia coli O157:H7 infection. Current Opin. Infect. Dis. 7:295-303.
25. O'Brien, A. D., and R. K. Holmes. 1987. Shiga and Shiga-like toxins. Microbiol. Rev. 51:206-220.
26. Obrig, T. G., P. J. Del Vecchio, M. A. Karmali, M. Petric, T. P. Moran, and T. K. Judge. 1987. Pathogenesis of haemolytic uraemic syndrome. Lancet ii:687.
27. Obrig, T. G., C. B. Louise, C. A. Lingwood, B. Boyd, L. Barley-Maloney L., and T. O. Daniel. 1993. Endothelial heterogeneity in Shiga toxin receptors and responses. J. Biol. Chem. 268:15484-15488.
28. Oelsehlaeger, T. A., T. J. Barrett, and D. J. Kopecko. 1994. Some structures and processes of human epithelial cells involved in uptake of enterohemorrhagic Escherichia coli O157:H7 strains. Infect. Immun. 62:5142-5150.
29. Parkos, C. A., C. Delp, M. A. Arnaout, and J. L. Madara. 1991. Neutrophil migration across a cultured intestinal epithelium. Dependence on a CD11b/ CD18-mediated event and enhanced efficiency in a physiological direction. J. Clin. Invest. 88:1605-1612.
30. Pinto, M., S. Robine-Leon, M. D. Appay, M. Kedinger, N. Triadou, E. Dussaulz, B. Lacroix, P. Simon-Assmann, K. Haffen, J. Fogh, and A. Zweibaum. 1983. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell 47:323-330.
31. Richardson, S. E., M. A. Karmali, L. E. Becker, and C. R. Smith. 1988. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum. Pathol. 19:1102-1108.
32. Ritchie, M., S. Partington, J. Jessop, and M. T. Kelly. 1992. Comparison of a direct fecal Shiga-like toxin assay and sorbitol-MacConkey agar culture for laboratory diagnosis of enterohemorrhagic Escherichia coli infection. J. Clin. Microbiol. 30:461-464.
33. Riu, C., C. Cabanas, and P. Aller. 1990. The induction of vimentin gene expression by sodium butyrate in human promonocytic leukemia U937 cells. Exp. Cell Res. 188:129-134.
34. Sandvig, K., M. Ryd, O. Garred, E. Schweda, P. K. Holm, and B. van Deurs. 1994. Retrograde transport from the golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP. J. Cell Biol. 126:53-64.
35. Schmilt, C. K., M. L. McKee, and A. D. O'Brien. 1991. Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H7 strain E32511. Infect. Immun. 59:1065-1073.
36. Scotland, S. M., S. Knutton, B. Said, and B. Rowe. 1994. Adherence to Caco-2 cells of Vero cytotoxin-producing strains of Escherichia coli belonging to serogroups other than O157, p. 257-264. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in Verocytotoxin-producing Escherichia coli infections. Elsevier, Amsterdam.
37. Tzipori, S. C. W. Chow, and H. R. Powell. 1988. Cerebral infection with Escherichia coli O157:H7 in humans and gnotobiotic piglets. J. Clin. Pathol. 41:1099-1103.
38. Tzipori, S., F. Gunzer, M. S. Donnenberg, L. De Montigny, J. B. Kaper, and A. Donohue-Rolfe. 1995. The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection. Infect. Immun. 63:3621-3627.
39. Wadolkowski, E. A., J. A. Burris, and A. D. O'Brien. 1990. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 58:2438-2445.